61
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Improving the global management of the neurogenic bladder patient: part I. The complexity of patients

, , , , , , , & show all
Pages 359-365 | Accepted 15 Dec 2005, Published online: 13 Jan 2006

References

  • Fingerman JS, Finkelstein LH. The overactive bladder in multiple sclerosis. J Am Osteopath Assoc 2000;100(Suppl 3):S9–S12
  • Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999;161:743–57
  • Giannantoni A, Scivoletto G, Di Stasi SM, et al. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil 1999;80:437–41
  • Kalsi V, Fowler CJ. Therapy insight: bladder dysfunction associated with multiple sclerosis. Nature Clin Pract Urol 2005;2:492–501
  • Betts CD, D’Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:245–50
  • Awad SA, Gajewski JB, Sogbein SK, et al. Relationship between neurological and urological status in patients with multiple sclerosis. J Urol 1984;132:499–502
  • Morgan M, Goodson J, Barnett G. Long-term changes in compliance with clinical guidelines through computer-based reminders. Proc AMIA Symp 1998; Harvard Ed, 1–5
  • Lomas J, Anderson GM, Domnik-Pierre K, et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. New Engl J Med 1989;321:1306–11
  • Zielstorff RD. Online practice guidelines: issues, obstacles, and future prospects. J Am Med Inform Assoc 1998;5:227–36
  • Zeilig G, Dolev M, Weingarden H, et al. Long-term morbidity and mortality after spinal cord injury: 50 years of follow-up. Spinal Cord 2000;38:563–6
  • Hackler RH. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol 1977;117:486–8
  • Frankel HL, Coll JR, Charlifue SW, et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord 1998;36:266–74
  • Lawrenson R, Wyndaele JJ, Vlachonikolis I, et al. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 2001;20:138–43
  • Yuruktumen A, Karcioglu O, Topacoglu H, et al. Acute renal failure associated with dysfunctioning detrusor muscle in multiple sclerosis. Adv Ther 2004;21:343–7
  • Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol 2000;163:768–72
  • Yavuzer G, Gok H, Tuncer S, et al. Compliance with bladder management in spinal cord injury patients. Spinal Cord 2000;38:762–5
  • Evans D. Lifestyle solutions for men with continence problems. Nurs Times 2005;101: 61–2, 64
  • Horrocks S, Somerset M, Stoddart H, et al. What prevents older people from seeking treatment for urinary incontinence? A qualitative exploration of barriers to the use of community continence services. Fam Pract 2004;21:689–96
  • Shaw C, Tansey R, Jackson C, et al. Barriers to help seeking in people with urinary symptoms. Fam Pract 2001;18:48–52
  • European Association of Urology. Guidelines on incontinence [Adapted by the EAU Working Group ‘Incontinence’, from Clinical Guidelines for the Management of Incontinence]. Plymouth (UK): Health Publication Ltd; 1999
  • Wyndaele JJ, Castro D, Madersbacher H, et al. Neurologic urinary and faecal incontinence. In Abrams P, Cardozo L, Khuory S et al. (Eds): Incontinence, Vol. 2, Chapter 17: Management. Plymouth (UK): Health Publication Ltd; 2005. pp. 1059–162
  • Stohrer M, Castro-Diaz D, Chartier-Kastler E, et al. Guidelines on neurogenic lower urinary tract dysfunction. European Association of Urology: 2003
  • Anderson K-E, Appell R, Cardozo L, et al. Chapter 14: pharmacological treatment of urinary incontinence. In: Incontinence, vol 2: management. Plymouth (UK): Health Publication Ltd; 2005. p. 809–54
  • Oshima S, Kirschner KL, Heinemann A, et al. Assessing the knowledge of future internists and gynecologists in caring for a woman with tetraplegia. Arch Phys Med Rehabil 1998;79:1270–9
  • Hawker KS, Frohman EM. Bladder, bowel, and sexual dysfunction in multiple sclerosis. Curr Treat Options Neurol 2001;3:207–14
  • Crayton H, Heyman RA, Rossman HS. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004;63(Suppl 5):S12–S18
  • Andersson KE, Pehrson R. CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs 2003;63:2595–611
  • Watanabe T, Perkash I, Constantinou CE. Modulation of detrusor contraction strength and micturition characteristics by intrathecal baclofen in anesthetized rats. J Urol 1997;157:2361–5
  • Aranda B, Cramer P. Effects of apomorphine and l-dopa on the parkinsonian bladder. Neurourol Urodyn 1993;12:203–9
  • Uchiyama T, Sakakibara R, Hattori T, et al. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson’s disease patients with the wearing-off phenomenon. Mov Disord 2003;18:573–8
  • Seif C, Herzog J, van der Horst C, et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 2004;55:118–20
  • Dalmose AL, Bjarkam CR, Sorensen JC, et al. Effects of high frequency deep brain stimulation on urine storage and voiding function in conscious minipigs. Neurourol Urodyn 2004;23:265–72
  • Metz LM, McGuinness SD, Harris C. Urinary tract infections may trigger relapse in multiple sclerosis. Axone 1998;19:67–70
  • Pesce F, Rubilotta E, D’Amico A, et al. Long-term anti- cholinergic therapy: duration and causes of discontinuation. Presented at ICS, 2003, Florence
  • Schurch B, de Seze M, Denys P, et al. Botulinum toxin is a safe and effective treatment for neurogenic urinary incontinence: results from a single-treatment, randomized, placebo-controlled 6-month study. J Urol 2005;174:196–200
  • Reitz A, Stohrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004;45:510–5
  • Stohrer M, Schurch B, Kramer G, et al. Botulinum-A toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures? Neurourol Urodyn 1999;18:401–2
  • Grosse J, Kramer G, Stohrer M. Success of repeat detrusor injections of botulinum A toxin in patient with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005;47:653–9
  • Bycroft J, Hamid R, Bywater H, et al. Variation in urological practice amongst spinal injuries units in the UK and Eire. Neurourol Urodyn 2004;23:252–6 [Discussion 7]
  • Jamil F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal Cord 2001;39:355–61
  • Yavuzer G, Gok, H, Tuncer S, et al. Compliance with bladder management in spinal cord injury patients. Spinal Cord 2000;38:762–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.